Another Chinese biotech files to go public in Hong Kong; A new ROR1 ADC deal

Shanghai Bao, Sichuan Biokin file IPOs in Hong Kong; Disc’s $200M offering

Plus, news about Har­mo­ny Bio­sciences and Re­verb Ther­a­peu­tics:

Gen­uine Biotech files for HKEX list­ing: The drug de­vel­op­er, which has mul­ti­ple lo­ca­tions in Chi­na,

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Source link

Visited 1 times, 1 visit(s) today

Leave a Reply

Your email address will not be published. Required fields are marked *